Statistics for Oryzon Genomics SA (id:4763 ORY)
Valuation metrics
Market cap
103.02M
Enterprise value
104.45M
Trailing P/E (ttm)
-28.69
Forward P/E
-9.53
PEG ratio
-9.53
Price/Sales (ttm)
6.51
Price/Book (mrq)
1.21
Enterprise Value/Revenue
Enterprise Value/EBITDA
-24.51
Overview
Shares outstanding
63.59M
Float
53.51M
Shares short
% Held by insiders
0.17%
% Held by institutions
0.01%
Average volume (10 days)
116.20K
Average volume (90 days)
Price summary
52-Week low
1.55
52-Week high
2.38
52-Week change
-27.53%
Beta
0.65
50-Day moving average
1.77
200-Day moving average
1.84
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-28.78%
Operating margin
-0.29%
Operational effectiveness
Return on assets
-3.14%
Return on equity
-4.10%
Income statement
Revenue (ttm)
0.25
Revenue per share (ttm)
0.25
Quarterly revenue growth (yoy)
Gross profit (ttm)
13.95M
EBITDA
86.66K
Net income to common (ttm)
-4,298,000.00
Diluted EPS (ttm)
-0.06
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0.00
Total cash per share (mrq)
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
Book value per share (mrq)
1.34
Cash flow
Cash flow statement
-3,798,910.00
Levered free cash flow (LFCF)
-3,352,943.00